CLBCX
Price
$34.80
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.45B
DBALX
Price
$13.18
Change
-$0.00 (-0.00%)
Updated
May 23 closing price
Net Assets
246.89M
Interact to see
Advertisement

CLBCX vs DBALX

Header iconCLBCX vs DBALX Comparison
Open Charts CLBCX vs DBALXBanner chart's image
American Funds American Balanced 529C
Price$34.80
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.45B
Davenport Balanced Income
Price$13.18
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets246.89M
CLBCX vs DBALX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. DBALX commentary
May 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and DBALX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 237B vs. DBALX (247M). DBALX pays higher dividends than CLBCX: DBALX (2.55) vs CLBCX (1.23). CLBCX was incepted earlier than DBALX: CLBCX (23 years) vs DBALX (9 years). CLBCX (1.35) is less costly to investors than DBALX (0.93). DBALX (45.00) and CLBCX (44.00) have comparable annual turnover. CLBCX has a lower initial minimum investment than DBALX: CLBCX (250) vs DBALX (5000). DBALX annual gain was more profitable for investors over the last year : 5.41 vs. CLBCX (4.46). DBALX return over 5 years is better than : 38.24 vs. CLBCX (34.45).
CLBCXDBALXCLBCX / DBALX
Total Expense Ratio1.350.93145%
Annual Report Gross Expense Ratio1.350.93145%
Fund Existence23 years9 years-
Gain YTD1.5242.26867%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets237B247M95,951%
Annual Yield % from dividends1.232.5548%
Returns for 1 year4.465.4182%
Returns for 3 years20.709.07228%
Returns for 5 years34.4538.2490%
Returns for 10 years53.10N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSPI14.610.24
+1.70%
CSP
USAC25.010.35
+1.42%
USA Compression Partners LP
NBIX120.181.06
+0.89%
Neurocrine Biosciences
LYRA0.09N/A
-0.65%
Lyra Therapeutics
EGBN17.47-0.19
-1.08%
Eagle Bancorp